期刊文献+

重症肺炎患者应用万古霉素后血药谷浓度影响因素 被引量:12

Influence factors of vancomycin serum trough concentration in patients with severe pneumonia
原文传递
导出
摘要 目的寻找影响重症肺炎患者应用万古霉素后血药谷浓度变化的因素并进行分析,为设计更加合理的个体化给药方案提供依据。方法选取2015年7月至2016年6月收住本院重症监护病房(ICU)的48例应用万古霉素治疗的重症肺炎患者,收集万古霉素血药谷浓度,治疗前至治疗后3 d内进行肾功能指标检测,考察万古霉素给药方案的临床疗效及内生肌酐清除率(CCR)对血清谷浓度的影响。结果 48例重症肺炎患者的谷浓度与年龄、体质量、血清白蛋白、万古霉素单位剂量、CCR的变化均线性相关(P均<0.05)。其中随着肾清除率增加,CCR>130[m L/(min·1.73 m^2)]的患者对于血清谷浓度具有显著性影响(P<0.05)。经调整给药方案后,不同肾功能状态的患者均可达到相同的临床疗效,有效率比较差异无统计学意义(P>0.05)。结论万古霉素治疗重症肺炎时,患者CCR是谷浓度的独立影响因素,在根据血清谷浓度监测结果调整给药方案后,不同肾功能状态的患者可以达到的临床疗效均较好。 Objective To analyze the influence factors on vancomycin serum trough concentration in patients with severe pneumonia in order to provide a reasonable references for personalized medication.Methods Forty-eight patients with severe pneumonia in intensive care unit(ICU) were enrolled from July 2015 to June 2016.The rate of serum trough concentration was collected,the renal function was detected,and the impact of creatinine clearance rate(CCR)in serum trough concentration were investigated and the clinical efficacy of the regiment was evaluated.Results There were significant correlation between age,weight,serum albumin level,CCR,dose of vancomycin per kilogram of body weight per day and serum trough concentration(both P〈0.05).Patients with CCR〉130[m L/(min · 1.73 m^2)]showed relatively significant influences to serum trough concentration(P〈0.05).After adjusting dose,patients with different renal function could still achieve the same efficacy,there was no significant difference in effective rate(P〉0.05).Conclusion CCR was an independent influencing factor for serum trough concentration of vancomycin,and patients with different renal function could achieve ideal efficacy giving the individualized regiment.
作者 代伟 陈瑞祥 温瑾 杨梅芳 DAI Wei;CHEN Rui-xiang;WEN Jin;YANG Mei-fang(Department of Pharmacy, the third people's Hospital of Yunnan Province, Kunming , Yunnan 650011;Guandu District People's Hospital of Kunming City, Kunming , Yunnan 650011, China)
出处 《热带医学杂志》 CAS 2018年第6期795-798,834,共5页 Journal of Tropical Medicine
关键词 肺炎 万古霉素 血药谷浓度 内生肌酐清除率 Pneumonia Vancomycin Serum trough concentration Creatinine clearance rate
  • 相关文献

参考文献9

二级参考文献65

  • 1邓晰明,樊俊红,汪华学,赵飞,邹琪.老年重症感染患者应用万古霉素的疗效及安全性[J].中国老年学杂志,2015,35(2):311-312. 被引量:4
  • 2抗菌药物临床应用指导原则[J].中国中医药现代远程教育,2005,3(2):13-15. 被引量:5
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3057
  • 4卢岩,孙健,张静,谈恒山.340例万古霉素血药浓度监测及临床用药合理性分析[J].中国医院药学杂志,2007,27(5):649-651. 被引量:38
  • 5MANDELL L A, WUNDERINK R G, ANZUETO A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults [J]. Clin Infect Dis, 2007, 44(Suppl 2): $27-72.
  • 6LIAPIKOU A, FERRER M, POLVERINO E, et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission [J]. Clin Infect Dis, 2009, 48(4): 377-385.
  • 7HAQUE N Z, ZUNIGA L C, PEYRANI P, et al. Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care -associated pneumonia [J]. Chest, 2010, 138(6): 1356-1362.
  • 8FREIFELD A G, BOW E J, SEPKOWITZ K A, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america [J]. Clin Infect Dis, 2011, 52(4): e56-93.
  • 9MATSUMOTO K, TAKESUE Y, OHMAGARI N, et al. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring [J]. J Infect Chemother, 2013, 19(3): 365-380.
  • 10RYBAK M, LOMAESTRO B, ROTSCHAFER J C, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists [J]. Am J Health Syst Pharm, 2009, 66(1): 82-98.

共引文献104

同被引文献137

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部